Erik Snapp is a litigation partner in the Chicago office of Winston & Strawn. His practice focuses on trials, litigation and counseling related to product liability issues, consumer fraud class actions, internal investigations, SEC investigations, contracts, and marketing and promotion of consumer products.
Mr. Snapp has extensive trial, litigation and internal investigation experience for some of the firm’s largest clients. Matters representative of Mr. Snapp’s experience include the following:
- Serving as first-chair trial counsel in a complex interstate child custody trial
- Defending medical device manufacturers in hip and spinal implant product liability litigation.
- Managing the firm’s defense of Pfizer and its Wyeth and Upjohn subsidiaries in state and federal product liability cases involving hormone therapy drugs.
- Defending a durable medical equipment manufacturer in federal and state criminal and civil investigations, and related consumer fraud class action litigation, focused on the manufacturer’s sales and contracting practices.
- Defending a pharmaceutical manufacturer in a False Claims Act federal investigation involving allegations of off-label promotion.
- Conducting an international internal investigation for a consumer products manufacturer regarding allegations of tax fraud.
- Defending a sub-prime lender in an SEC investigation focused on the adequacy of the lender’s reserves and its loss disclosures.
- Defending a top executive of a sub-prime lender in an SEC investigation focused on the lender’s loan loss reserves and related disclosures.
- Defending Philip Morris USA Inc. in a consumer fraud class action involving claims that Philip Morris USA violated the Missouri Merchandising Practices Act by selling “light” cigarettes to Missouri consumers.
- Defending Philip Morris U.S.A. in product liability litigation, including class action trials in Florida and Ohio.
- Serving as national counsel to a joint venture owner in nationwide state court and MDL consumer fraud class action litigation related to the joint venture’s pricing, sales and marketing practices.
- Managing and leading multi-firm trial teams defending a pharmaceutical manufacturer against allegations by multiple plaintiffs that the manufacturer’s product caused cancer.
In addition, Mr. Snapp has written numerous appellate briefs submitted to the U.S. Supreme Court and state and federal appellate courts, and has argued several cases before the Seventh Circuit U.S. Court of Appeals and the Illinois Appellate Court. Mr. Snapp’s successes in the Seventh Circuit have included Buchmeier v. United States, 581 F.3d 561 (7th Cir. 2009)(en banc) and Sanders v. Cotton, 398 F.3d 572 (7th Cir. 2005).
Prior to joining Winston & Strawn, Mr. Snapp served as a law clerk for the Hon. Bruce D. Willis of the Minnesota Court of Appeals.
Mr. Snapp currently serves on the board of directors of The Musical Offering, a non-profit community music school, and has previously served on the board of directors of Art Encounter, a community-based non-profit organization dedicated to visual arts education. He also has devoted hundreds of hours to pro bono work on behalf of indigent clients as part of the firm’s strong commitment to community service. Mr. Snapp has also been certified as a volunteer mediator by the Center for Conflict Resolution.
Mr. Snapp received a B.S., cum laude, from St. John’s University in 1990. He received a J.D., cum laude, in 1995 from the University of Minnesota Law School, where he was a member of the Minnesota Law Review and the Philip C. Jessup International Law Moot Court.
Speeches and Publications
- Mr. Snapp served as a panelist on a live Knowledge Congress webcast titled "FDA's Off-Label Information: A 2013 Update." Mr. Snapp discussed “Recent Regulatory and Enforcement Actions: What Do They Mean for Your Compliance Efforts?”
- Mr. Snapp discussed “Minimizing the Risk of the Sales Force Crossing the Line” as a panelist at the American Conference Institute’s “Pharmaceutical and Medical Device Company’s Guide to Off-Label Communications” conference on July 15, 2009 in Philadelphia.
- Mr. Snapp co-authored “Mandatory Compliance with “Voluntary” Codes,” which was published in October 2008 in Law360’s Health Law section.
- Mr. Snapp co-authored “The FDA’s medical reprint policy — a cautious compromise,” which was published in August 2008 in Scrip World Pharmaceutical News.